Gene · 2357
Papers4,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of small-molecule fluorescent probes targeting neutrophils via N-formyl peptide receptors. | RSC Med Chem | 2025 | 39886349 | PubTator, text mining | PubMed |
| Knockout or treatment with an antagonist of formyl peptide receptor 1 protects mice from sepsis by inhibiting inflammation. | Cytokine | 2025 | 39879890 | PubTator, text mining | PubMed |
| Cell signaling communication within papillary craniopharyngioma revealed by an integrated analysis of single-cell RNA sequencing and bulk RNA sequencing. | J Transl Med | 2025 | 39871369 | PubTator, text mining | PubMed |
| Maternal exposure to nicotine causes oxidative stress and inflammatory changes in the ovaries of rats' adult offspring. | Reprod Toxicol | 2025 | 39824327 | PubTator, text mining | PubMed |
| Adenosine accumulation in the blood of newborn mice weakens antimicrobial host defenses. | J Leukoc Biol | 2025 | 39824218 | PubTator, text mining | PubMed |
Identification of key antifibrotic targets FPR1, TAS2R5, and LRP2BP of valsartan in diabetic nephropathy: A transcriptomics-driven study integrating machine learning, molecular docking, and dynamics simulations. | Int J Biol Macromol | 2025 | 39814306 | PubTator, text mining | PubMed |
| A Comparative Study on the Progression of Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. | Oncology | 2025 | 39778540 | PubTator, text mining | PubMed |
| The small molecule peptide ANXA114-26 inhibits ovarian cancer cell proliferation and reverses cisplatin resistance by binding to the formyl peptide receptors receptor. | J Cell Commun Signal | 2025 | 39712859 | PubTator, text mining | PubMed |
| Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation. | Pharmacol Ther | 2025 | 39566561 | PubTator, text mining | PubMed |
| Discovery of five diagnostic biomarkers associated with immune cell infiltration in cases of acute myocardial infarction. | Minerva Cardiol Angiol | 2025 | 39495540 | PubTator, text mining | PubMed |
| Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles. | Br J Pharmacol | 2025 | 39294930 | PubTator, text mining | PubMed |
| Distinct Gene Expression and Immune Features Between Different Neutrophil Extracellular Trap-Related Osteosarcoma Subtypes. | Appl Biochem Biotechnol | 2025 | 39096473 | PubTator, text mining | PubMed |
| Gene Regulation of Neutrophils Mediated Liver and Lung Injury through NETosis in Acute Pancreatitis. | Inflammation | 2025 | 38884700 | PubTator, text mining | PubMed |
| Contribution of Sex Differences to the Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD). | Int J Transl Med (Basel) | 2024 | 40988882 | PubTator, text mining | PubMed |
| Exploring and analyzing two aging related genes FPR1 and UCHL1 and their potential molecular mechanisms in aggravating lumbar disc herniation. | J Orthop Surg Res | 2024 | 39695855 | PubTator, text mining | PubMed |
| Neutrophils in the Spotlight-An Analysis of Neutrophil Function and Phenotype in ARDS. | Int J Mol Sci | 2024 | 39684262 | PubTator, text mining | PubMed |
| Serum mitochondrial-encoded NADH dehydrogenase 6 and Annexin A1 as novel biomarkers for mortality prediction in critically ill patients with sepsis. | Front Immunol | 2024 | 39611143 | PubTator, text mining | PubMed |
| "Ensembled transfer learning approach for error reduction in landslide susceptibility mapping of the data scare region". | Sci Rep | 2024 | 39580472 | PubTator, text mining | PubMed |
| CRBPSA: CircRNA-RBP interaction sites identification using sequence structural attention model. | BMC Biol | 2024 | 39543602 | PubTator, text mining | PubMed |
| Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist. | ACS Pharmacol Transl Sci | 2024 | 39539264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2357/papers?page=12